PubHive Ltd., a leading provider of AI-powered scientific literature and safety information workflows, has unveiled a ground-breaking solution for life science companies and Clinical Research Organizations (CROs) – a centralized Summary of Product Characteristics (SmPC) management system with AI-powered pharmacovigilance workflows. This innovative offering is designed to enhance speed, compliance, and patient safety by simplifying processes and empowering pharmacovigilance teams to work more efficiently.
PubHive's unified platform aims to eliminate siloed information and manual processes by consolidating all SmPC data and documents into a centralized repository. This not only ensures consistency but also enhances accessibility across teams and locations. The introduction of AI-powered features automates time-consuming tasks such as document analysis and version control, allowing pharmacovigilance (PV) experts to concentrate on high-value activities like signal detection and risk assessment.
Key benefits of PubHive's Centralized SmPC and AI-powered Pharmacovigilance Workflows include:
• Centralized SmPC Management: PubHive offers a centralized repository for SmPCs, streamlining access, updates, and distribution. This eliminates scattered and outdated SmPCs, ensuring accuracy and consistency.
• AI-powered Pharmacovigilance: Harnessing the power of artificial intelligence, PubHive's algorithms analyze vast amounts of data to detect adverse events, identify trends, and streamline reporting, enhancing the efficiency of pharmacovigilance efforts.
• Compliance and Efficiency: PubHive's automated workflows ensure compliance with regulatory requirements, making pharmacovigilance processes efficient, accurate, and aligned with industry standards.
• Collaboration and Communication: Foster collaboration within organizations and with external stakeholders through seamless sharing of information and insights. This improves decision-making and ultimately enhances patient safety.
• Real-time Alerts and Notifications: Stay informed with real-time alerts on critical pharmacovigilance events, allowing proactive addressing of potential issues and ensuring swift action when needed.
• Customizable Workflows: Create standardized research pathways tailored to specific PV workflows, ensuring users can access resources and data tailored to their requirements.
Benefits for Life Science Companies and CROs include reduced costs, increased efficiency through automation, improved data visibility for faster risk identification and mitigation, enhanced regulatory compliance, and improved collaboration within and across teams.
Click here to read the original press release.
More News in this Theme
